The drugmaker is a great dividend payer. Although broader equities performed well in 2025, volatility was significant, ...

AstraZeneca on Tuesday said it would delist its American Depositary Shares and debt securities from Nasdaq and complete a ...

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory ...

Recent health sector developments highlight Moderna and Merck's promising skin cancer vaccine trial alongside China's declining birthrate, and significant business moves from pharmaceuticals giants ...

AstraZeneca (NASDAQ:AZN) has announced it will shift its US listing from Nasdaq to the New York Stock Exchange, delisting its ...

AstraZeneca (NASDAQ: AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...

AstraZeneca (NASDAQ: AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...

A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...

New York AG Letitia James charged former Emergent BioSolutions CEO Robert Kramer with insider trading tied to COVID-19 ...

New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.

Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...

New York Attorney General Letitia James filed suit against the former head of Emergent BioSolutions, accusing him of insider trading for selling his shares in the company before disclosing ...